Armodafinil Tablet
FDA Label NDC 55700-510

39 label sections · Submitted to the FDA by Quality Care Products Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Quality Care Products Llc for the product Armodafinil (NDC 55700-510). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1 indications and usage, 2.1 dosage in obstructive sleep apnea (osa) and narcolepsy, 2.2 dosage in shift work disorder (swd), 2.3 dosage modification in patients with severe hepatic impairment, 2.4 use in geriatric patients, 3 dosage forms and strengths, 4 contraindications, 5.1 serious dermatologic reactions, including stevens-johnson syndrome and toxic epidermal necrosis, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.